← Open Payments lookup

ABIODUN OLATUBOSUN: Open Payments

NPI 1215531678 · BLOOMFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$899 in 48 payments from 9 companies in 2025. Trend: 2023 $921 · 2024 $1,083 · 2025 $899

Food & beverage: $899
CompanyPaymentsAmount
Alkermes, Inc.17$330
Otsuka America Pharmaceutical, Inc.10$203
Janssen Pharmaceuticals, Inc8$144
E.R. Squibb & Sons, L.L.C.4$66
Teva Pharmaceuticals USA, Inc.3$48
ABBVIE INC.2$38
Neurocrine BioSciences, Inc.2$37
Lundbeck LLC1$18
Almatica Pharma LLC1$16

Products named: ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ABILIFY MAINTENA, COBENFY, REXULTI, VRAYLAR, INGREZZA.

Industry payments across NJ — which companies pay providers there.